Investments

Braidwell’s $45 Million Investment Fuels BrightSpring’s 86% Stock Surge in Healthcare Services

Connecticut-based Braidwell initiated a new position in BrightSpring Health Services (NASDAQ:BTSG) in its February 17, 2026, SEC filing, acquiring 1,195,786 shares with an estimated transaction value of $44.78 million. This

Your Trusted Source for Accurate and Timely Updates!

Our commitment to accuracy, impartiality, and delivering breaking news as it happens has earned us the trust of a vast audience. Stay ahead with real-time updates on the latest events, trends.

Popular Post

Lasted Investments

Amplitude’s Expansion: Acquiring Kraftful

Amplitude Acquires AI-Native Voice of Customer Startup, Kraftful Amplitude, Inc., a San Francisco-based company, has recently acquired Kraftful, a Voice

Flame Buys Innovation Hub: Torch’s Acquisition of Praxis Labs

Summary: Torch, a San Francisco-based company, has acquired Praxis Labs, an AI learning platform provider. The financial details of the

Harmonic Secures $100M in Series B Funding for Growth and Innovation

Summary: Harmonic, an AI lab in Palo Alto, secured $100 million in Series B funding to advance Mathematical Superintelligence (MSI).

Bilt secures $250 million in funding, valued at $10.75 billion

Summary: Bilt, a NYC-based payments and commerce network, secured $250M in funding at a valuation of $10.75 Billion. The funding

Water Harvesting Secures $8M in Series A-1 Funding for Growth

Water Harvesting Inc. Secures $8M in Series A-1 Financing and Corporate Reorganization Summary: Water Harvesting Inc., a Fremont, CA-based climate

Aqtual Secures $31 Million in Series B Investment Round

Summary: Aqtual, a precision medicine company in Hayward, CA, raised $31M in Series B funding. The funding came from investors

iCapital Achieves Record $820M Capital Raise, Surges to $7.5 Billion Valuation

Summary: iCapital, a NYC-based fintech company, raised over $820M in its latest financing round, reaching a valuation of over $7.5

Nuclidium Secures €84 Million in Series B Investment Round

Summary: Nuclidium, a Swiss radiopharmaceutical company, secured €84M in Series B funding. The funding will be used to advance its